Pancrylis
mRNA therapy for pancreatic cancer with rapid tumor targeting.
zestrin.com
Strategy-led pharmaceutical research and oncology therapeutics built for complex decisions.
Trusted pharmaceutical research and oncology therapeutics with a focus on clarity, scale, and long-term partnerships.
Performance highlights
- Dedicated client teams
- Quarterly performance reviews
- Compliance-first operations
- 24/7 response coverage
mRNA oncology portfolio
Our pipeline targets aggressive cancers with precision mRNA constructs and adaptive delivery systems.
Smallara
Small-cell lung cancer therapy engineered for durable response.
Testemra
Testicular cancer treatment designed for resilience and recovery.
Lymnovis
Non-Hodgkin lymphoma therapy focusing on immune modulation.
mRNA therapeutics
Purpose-built support tailored for your operating model.
Clinical trial partnerships
Purpose-built support tailored for your operating model.
Regulatory strategy
Purpose-built support tailored for your operating model.
Oncology research
Purpose-built support tailored for your operating model.
Connect with Zestrin Phrama
Reach us at general@zestrin.com for proposals or partnerships.